XML 135 R121.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Financial Data (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Net revenue $ 530.5 $ 435.6 $ 414.9 $ 384.9 $ 470.3 $ 393.9 $ 371.7 $ 375.4 $ 1,765.9 $ 1,611.3 $ 1,623.8
Gross profit 255.2 198.0 183.4 176.4 220.4 185.2 170.1 166.8 813.0 742.5 708.6
Operating income 93.7 49.9 33.5 37.6 76.9 45.9 20.4 34.0 214.7 177.2 145.7
Net income (loss) attributable to Bruker Corporation $ (3.4) $ 37.0 $ 23.4 $ 21.6 $ 69.0 $ 46.5 $ 14.5 $ 23.6 $ 78.6 $ 153.6 $ 101.6
Net income (loss) per common share attributable to Bruker Corporation shareholders:                      
Basic (in dollars per share) $ (0.02) $ 0.23 $ 0.15 $ 0.14 $ 0.43 $ 0.29 $ 0.09 $ 0.14 $ 0.50 $ 0.95 $ 0.60
Diluted (in dollars per share) $ (0.02) $ 0.23 $ 0.15 $ 0.13 $ 0.43 $ 0.29 $ 0.09 $ 0.14 $ 0.49 $ 0.95 $ 0.60
Impairment of assets $ 0.8     $ 0.3 $ 0.1   $ 0.7   $ 1.1 $ 0.8 $ 4.6
Gain on bargain purchase                 $ 0.6 9.2  
Incremental income tax provision 68.9                    
MERLIN Diagnostika GmbH                      
Net income (loss) per common share attributable to Bruker Corporation shareholders:                      
Gain on bargain purchase   $ 1.1                  
Adjustment to bargain purchase gain $ 0.5                    
Oxford Instruments Superconducting Wire LLC                      
Net income (loss) per common share attributable to Bruker Corporation shareholders:                      
Gain on bargain purchase         $ 9.2         $ 9.2